121 related articles for article (PubMed ID: 35089107)
1. Evaluation of Curcumin Therapeutic Effects on Histological Subtypes of Canine Mammary Gland Tumours.
Turna O; Baykal A; Sozen Kucukkara E; Deveci Ozkan A; Guney Eskiler G; Yıldırım F
Nutr Cancer; 2022; 74(8):3015-3025. PubMed ID: 35089107
[TBL] [Abstract][Full Text] [Related]
2. Kv 11.1 Expression Is Associated With Malignancy of Canine Mammary Gland Tumors.
Lee N; Lee S; Kim W
In Vivo; 2024; 38(2):719-724. PubMed ID: 38418114
[TBL] [Abstract][Full Text] [Related]
3. Utility of the second-generation curcumin analogue RL71 in canine histiocytic sarcoma.
Kelly B; Thamm D; Rosengren RJ
Vet Res Commun; 2024 Feb; 48(1):563-568. PubMed ID: 37597087
[TBL] [Abstract][Full Text] [Related]
4. Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines.
Ramachandran C; Rodriguez S; Ramachandran R; Raveendran Nair PK; Fonseca H; Khatib Z; Escalon E; Melnick SJ
Anticancer Res; 2005; 25(5):3293-302. PubMed ID: 16101141
[TBL] [Abstract][Full Text] [Related]
5. Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin.
Ramachandran C; You W
Breast Cancer Res Treat; 1999 Apr; 54(3):269-78. PubMed ID: 10445426
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial Effects of Curcumin with an Anti-Neoplastic Agent on Head and Neck Squamous Cell Carcinoma Through the Regulation of EGFR-ERK1/2 and Apoptotic Signaling Pathways.
Sivanantham B; Sethuraman S; Krishnan UM
ACS Comb Sci; 2016 Jan; 18(1):22-35. PubMed ID: 26505786
[TBL] [Abstract][Full Text] [Related]
7. Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice.
Masuelli L; Benvenuto M; Fantini M; Marzocchella L; Sacchetti P; Di Stefano E; Tresoldi I; Izzi V; Bernardini R; Palumbo C; Mattei M; Lista F; Galvano F; Modesti A; Bei R
J Biol Regul Homeost Agents; 2013; 27(1):105-19. PubMed ID: 23489691
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of 5-aminolevulinic acid-based photodynamic therapy in different subtypes of canine mammary gland cancer cells.
Turna O; Baykal A; Sozen Kucukkara E; Ozten O; Deveci Ozkan A; Guney Eskiler G; Kamanli AF; Bilir C; Yildiz SZ; Kaleli S; Ucmak M; Kasikci G; Lim HS
Lasers Med Sci; 2022 Mar; 37(2):867-876. PubMed ID: 33937952
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptotic death by curcumin in human tongue squamous cell carcinoma SCC-4 cells is mediated through endoplasmic reticulum stress and mitochondria-dependent pathways.
Ip SW; Wu SY; Yu CC; Kuo CL; Yu CS; Yang JS; Lin ZP; Chiou SM; Chung HK; Ho HC; Chung JG
Cell Biochem Funct; 2011 Dec; 29(8):641-50. PubMed ID: 21887696
[TBL] [Abstract][Full Text] [Related]
10. Curcumin inhibits autocrine growth hormone-mediated invasion and metastasis by targeting NF-κB signaling and polyamine metabolism in breast cancer cells.
Coker-Gurkan A; Celik M; Ugur M; Arisan ED; Obakan-Yerlikaya P; Durdu ZB; Palavan-Unsal N
Amino Acids; 2018 Aug; 50(8):1045-1069. PubMed ID: 29770869
[TBL] [Abstract][Full Text] [Related]
11. Curcumin as therapeutics for the treatment of head and neck squamous cell carcinoma by activating SIRT1.
Hu A; Huang JJ; Li RL; Lu ZY; Duan JL; Xu WH; Chen XP; Fan JP
Sci Rep; 2015 Aug; 5():13429. PubMed ID: 26299580
[TBL] [Abstract][Full Text] [Related]
12. Curcumin induces G0/G1 arrest and apoptosis in hormone independent prostate cancer DU-145 cells by down regulating Notch signaling.
Sha J; Li J; Wang W; Pan L; Cheng J; Li L; Zhao H; Lin W
Biomed Pharmacother; 2016 Dec; 84():177-184. PubMed ID: 27657825
[TBL] [Abstract][Full Text] [Related]
13. Curcumin downregulates the PI3K-AKT-mTOR pathway and inhibits growth and progression in head and neck cancer cells.
Borges GA; Elias ST; Amorim B; de Lima CL; Coletta RD; Castilho RM; Squarize CH; Guerra ENS
Phytother Res; 2020 Dec; 34(12):3311-3324. PubMed ID: 32628350
[TBL] [Abstract][Full Text] [Related]
14. Synthetic curcumin analog UBS109 inhibits the growth of head and neck squamous cell carcinoma xenografts.
Zhu S; Moore TW; Morii N; Howard RB; Culver D; Arrendale RF; Reddy P; Evers TJ; Zhang H; Sica G; Chen ZG; Sun A; Fu H; Khuri FR; Shin DM; Snyder JP; Shoji M
Curr Cancer Drug Targets; 2014; 14(4):380-93. PubMed ID: 24628271
[TBL] [Abstract][Full Text] [Related]
15. Curcumin enhanced antiproliferative effect of mitomycin C in human breast cancer MCF-7 cells in vitro and in vivo.
Zhou QM; Wang XF; Liu XJ; Zhang H; Lu YY; Su SB
Acta Pharmacol Sin; 2011 Nov; 32(11):1402-10. PubMed ID: 21986579
[TBL] [Abstract][Full Text] [Related]
16. ST09, A Novel Curcumin Derivative, Blocks Cell Migration by Inhibiting Matrix Metalloproteases in Breast Cancer Cells and Inhibits Tumor Progression in EAC Mouse Tumor Models.
Nirgude S; Mahadeva R; Koroth J; Kumar S; Kumar KSS; Gopalakrishnan V; S Karki SS; Choudhary B
Molecules; 2020 Sep; 25(19):. PubMed ID: 33008036
[TBL] [Abstract][Full Text] [Related]
17. Curcumin in Treating Breast Cancer: A Review.
Wang Y; Yu J; Cui R; Lin J; Ding X
J Lab Autom; 2016 Dec; 21(6):723-731. PubMed ID: 27325106
[TBL] [Abstract][Full Text] [Related]
18. Curcumin enhances the anticancer effects of trichostatin a in breast cancer cells.
Yan G; Graham K; Lanza-Jacoby S
Mol Carcinog; 2013 May; 52(5):404-11. PubMed ID: 22290509
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of selective COX-2 inhibitors as therapeutic agents against canine mammary tumors.
Saito T; Tamura D; Asano R
Oncol Rep; 2014 Apr; 31(4):1637-44. PubMed ID: 24503782
[TBL] [Abstract][Full Text] [Related]
20. Superoxide anion and proteasomal dysfunction contribute to curcumin-induced paraptosis of malignant breast cancer cells.
Yoon MJ; Kim EH; Lim JH; Kwon TK; Choi KS
Free Radic Biol Med; 2010 Mar; 48(5):713-26. PubMed ID: 20036734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
